539 related articles for article (PubMed ID: 15896665)
1. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.
Bray M; Geisbert TW
Int J Biochem Cell Biol; 2005 Aug; 37(8):1560-6. PubMed ID: 15896665
[TBL] [Abstract][Full Text] [Related]
2. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.
Gupta M; Spiropoulou C; Rollin PE
Virology; 2007 Jul; 364(1):45-54. PubMed ID: 17391724
[TBL] [Abstract][Full Text] [Related]
3. Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype).
Hutchinson KL; Villinger F; Miranda ME; Ksiazek TG; Peters CJ; Rollin PE
J Med Virol; 2001 Nov; 65(3):561-6. PubMed ID: 11596094
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
Gibb TR; Bray M; Geisbert TW; Steele KE; Kell WM; Davis KJ; Jaax NK
J Comp Pathol; 2001 Nov; 125(4):233-42. PubMed ID: 11798240
[TBL] [Abstract][Full Text] [Related]
5. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.
Bosio CM; Aman MJ; Grogan C; Hogan R; Ruthel G; Negley D; Mohamadzadeh M; Bavari S; Schmaljohn A
J Infect Dis; 2003 Dec; 188(11):1630-8. PubMed ID: 14639532
[TBL] [Abstract][Full Text] [Related]
6. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.
Gupta M; Goldsmith CS; Metcalfe MG; Spiropoulou CF; Rollin PE
Virology; 2010 Jun; 402(1):203-8. PubMed ID: 20394957
[TBL] [Abstract][Full Text] [Related]
7. Ebola hemorrhagic fever and septic shock.
Bray M; Mahanty S
J Infect Dis; 2003 Dec; 188(11):1613-7. PubMed ID: 14639530
[No Abstract] [Full Text] [Related]
8. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
Baize S; Leroy EM; Georges-Courbot MC; Capron M; Lansoud-Soukate J; Debré P; Fisher-Hoch SP; McCormick JB; Georges AJ
Nat Med; 1999 Apr; 5(4):423-6. PubMed ID: 10202932
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of filoviral haemorrhagic fevers.
Mahanty S; Bray M
Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
[TBL] [Abstract][Full Text] [Related]
10. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.
Davis KJ; Anderson AO; Geisbert TW; Steele KE; Geisbert JB; Vogel P; Connolly BM; Huggins JW; Jahrling PB; Jaax NK
Arch Pathol Lab Med; 1997 Aug; 121(8):805-19. PubMed ID: 9278608
[TBL] [Abstract][Full Text] [Related]
11. An analysis of features of pathogenesis in two animal models of Ebola virus infection.
Ryabchikova EI; Kolesnikova LV; Luchko SV
J Infect Dis; 1999 Feb; 179 Suppl 1():S199-202. PubMed ID: 9988185
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
Geisbert TW; Hensley LE; Larsen T; Young HA; Reed DS; Geisbert JB; Scott DP; Kagan E; Jahrling PB; Davis KJ
Am J Pathol; 2003 Dec; 163(6):2347-70. PubMed ID: 14633608
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and pathobiology of Ebolavirus infection.
Ansari AA
J Autoimmun; 2014 Dec; 55():1-9. PubMed ID: 25260583
[TBL] [Abstract][Full Text] [Related]
14. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
15. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.
Larsen T; Stevens EL; Davis KJ; Geisbert JB; Daddario-DiCaprio KM; Jahrling PB; Hensley LE; Geisbert TW
J Infect Dis; 2007 Nov; 196 Suppl 2():S323-8. PubMed ID: 17940967
[TBL] [Abstract][Full Text] [Related]
16. Other viral bioweapons: Ebola and Marburg hemorrhagic fever.
Salvaggio MR; Baddley JW
Dermatol Clin; 2004 Jul; 22(3):291-302, vi. PubMed ID: 15207310
[TBL] [Abstract][Full Text] [Related]
17. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
18. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.
Twenhafel NA; Mattix ME; Johnson JC; Robinson CG; Pratt WD; Cashman KA; Wahl-Jensen V; Terry C; Olinger GG; Hensley LE; Honko AN
Vet Pathol; 2013 May; 50(3):514-29. PubMed ID: 23262834
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
Geisbert TW; Hensley LE; Jahrling PB; Larsen T; Geisbert JB; Paragas J; Young HA; Fredeking TM; Rote WE; Vlasuk GP
Lancet; 2003 Dec; 362(9400):1953-8. PubMed ID: 14683653
[TBL] [Abstract][Full Text] [Related]
20. Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage.
Barrientos LG; Rollin PE
Virology; 2007 Feb; 358(1):1-9. PubMed ID: 16982079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
